Cancer Biomarkers in Body Fluids
Liquid biopsy shows promise for cancer screening and diagnostics. This reprint collects recent scientific literature on the identification and application of tumor biomarkers in biological fluids to improve the diagnosis of cancer and the identification of optimal therapeutic strategies.
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_98869 | ||
| 005 | 20230405 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230405s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-6648-1 | ||
| 020 | |a 9783036566498 | ||
| 020 | |a 9783036566481 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-6648-1 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 100 | 1 | |a Bianchi, Fabrizio |4 edt | |
| 700 | 1 | |a Bianchi, Fabrizio |4 oth | |
| 245 | 1 | 0 | |a Cancer Biomarkers in Body Fluids |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (490 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Liquid biopsy shows promise for cancer screening and diagnostics. This reprint collects recent scientific literature on the identification and application of tumor biomarkers in biological fluids to improve the diagnosis of cancer and the identification of optimal therapeutic strategies. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Oncology |2 bicssc | |
| 653 | |a primary breast cancer | ||
| 653 | |a circulating nucleosomes | ||
| 653 | |a circulating tumor cells | ||
| 653 | |a plasminogen activator inhibitor-1 | ||
| 653 | |a cytokines | ||
| 653 | |a prostate cancer | ||
| 653 | |a breast cancer | ||
| 653 | |a treatment decisions | ||
| 653 | |a exosomes | ||
| 653 | |a molecular composition | ||
| 653 | |a cancer pathogenesis | ||
| 653 | |a diagnostics | ||
| 653 | |a therapeutics | ||
| 653 | |a leptomeningeal metastasis | ||
| 653 | |a cerebrospinal fluid | ||
| 653 | |a extracellular vesicle | ||
| 653 | |a biomarker | ||
| 653 | |a RNA sequencing | ||
| 653 | |a small non-coding RNA | ||
| 653 | |a microRNA | ||
| 653 | |a exo-oncomiRNAS | ||
| 653 | |a TWEAK | ||
| 653 | |a semen | ||
| 653 | |a rheumatoid factor | ||
| 653 | |a autoimmunity | ||
| 653 | |a autoantibodies | ||
| 653 | |a cancer | ||
| 653 | |a predictive biomarker | ||
| 653 | |a prognostic biomarker | ||
| 653 | |a cancer progression | ||
| 653 | |a cancer development | ||
| 653 | |a immunotherapy | ||
| 653 | |a cancer susceptibility | ||
| 653 | |a tumor recurrence | ||
| 653 | |a tumor load | ||
| 653 | |a fecal immunochemical test (FIT) | ||
| 653 | |a colonoscopy | ||
| 653 | |a flexible sigmoidoscopy | ||
| 653 | |a liquid biopsy | ||
| 653 | |a mRNA | ||
| 653 | |a ctDNA | ||
| 653 | |a proteins | ||
| 653 | |a extracellular vesicles | ||
| 653 | |a biomarkers | ||
| 653 | |a exosome | ||
| 653 | |a lung cancer | ||
| 653 | |a miRNA | ||
| 653 | |a plasma | ||
| 653 | |a serum | ||
| 653 | |a volatile organic compounds (VOCs) | ||
| 653 | |a gas chromatography (GC) | ||
| 653 | |a mass spectrometry (MS) | ||
| 653 | |a headspace solid phase microextraction (HS-SPME) | ||
| 653 | |a breast cancer biomarkers | ||
| 653 | |a principal component analysis (PCA) | ||
| 653 | |a linear discriminant analysis (LDA) | ||
| 653 | |a principal component regression (PCR) | ||
| 653 | |a cfDNA | ||
| 653 | |a hereditary and familial pancreatic cancer | ||
| 653 | |a somatic mutation profiling | ||
| 653 | |a potentially druggable genes | ||
| 653 | |a uveal melanoma | ||
| 653 | |a circulating tumor DNA | ||
| 653 | |a next generation sequencing | ||
| 653 | |a PKC inhibitor | ||
| 653 | |a treatment | ||
| 653 | |a response | ||
| 653 | |a melanoma | ||
| 653 | |a ovarian cancer | ||
| 653 | |a lipidomics | ||
| 653 | |a lipid | ||
| 653 | |a prognosis | ||
| 653 | |a ceramide | ||
| 653 | |a phospholipid | ||
| 653 | |a plasmalogen | ||
| 653 | |a patient stratification | ||
| 653 | |a outcome | ||
| 653 | |a personalized medicine | ||
| 653 | |a neuroblastoma | ||
| 653 | |a immune monitoring | ||
| 653 | |a anti-GD2 | ||
| 653 | |a IL-2 | ||
| 653 | |a GM-CSF | ||
| 653 | |a ASCT | ||
| 653 | |a dinutuximab | ||
| 653 | |a anti-PD-1 | ||
| 653 | |a urothelial cancer | ||
| 653 | |a blood biomarkers | ||
| 653 | |a NETs | ||
| 653 | |a disease modelling | ||
| 653 | |a machine learning | ||
| 653 | |a metabolic signaling | ||
| 653 | |a molecular pathways | ||
| 653 | |a plasma metabolites | ||
| 653 | |a diagnostic biomarkers | ||
| 653 | |a urine | ||
| 653 | |a urine liquid biopsy | ||
| 653 | |a DNA | ||
| 653 | |a sncRNA | ||
| 653 | |a bladder cancer | ||
| 653 | |a metabolic pathways | ||
| 653 | |a metabolism | ||
| 653 | |a metabolomics | ||
| 653 | |a epigenetics | ||
| 653 | |a miRNAs | ||
| 653 | |a epigenetic biomarkers | ||
| 653 | |a DNA methylation | ||
| 653 | |a micro-RNAs | ||
| 653 | |a human papillomavirus | ||
| 653 | |a oropharyngeal squamous cell carcinoma | ||
| 653 | |a treatment de-escalation | ||
| 653 | |a E7 oncoprotein | ||
| 653 | |a HPV DNA | ||
| 653 | |a HPV antibodies | ||
| 653 | |a ELISA | ||
| 653 | |a cancer biomarkers | ||
| 653 | |a diagnosis | ||
| 653 | |a early detection | ||
| 653 | |a n/a | ||
| 653 | |a early diagnosis | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6922 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/98869 |7 0 |z DOAB: description of the publication |